These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35362842)

  • 1. ASO Author Reflections: Optimized Cutoff Value of Albumin-Bilirubin Score to Predict Prognosis of Patients with Esophageal Squamous Cell Carcinoma After Radical Resection.
    Shinozuka T; Kanda M; Kodera Y
    Ann Surg Oncol; 2022 Aug; 29(8):4897-4898. PubMed ID: 35362842
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Prognostic Stratification and the Value of Adjuvant Therapy in Thoracic Esophageal Squamous Cell Carcinoma Patients After Esophagectomy.
    Deng W; Chen J; Xiao Z
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):802-803. PubMed ID: 31654164
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Association Between Preoperative Coagulation Status and Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma After Neoadjuvant Treatment.
    Sugiyama F; Kanda M; Kodera Y
    Ann Surg Oncol; 2024 May; 31(5):3473-3474. PubMed ID: 38261127
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of the Modified Albumin-Bilirubin Grade with Survival Outcomes in Esophageal Squamous Cell Carcinoma.
    Gu YM; Zhang HL; Chen LQ
    Ann Surg Oncol; 2022 Aug; 29(8):4681-4682. PubMed ID: 35527327
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Decrease of Albumin and Derived Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy Reflect the Worse Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
    Abe T; Oshikiri T; Goto H; Kato T; Horikawa M; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
    Ann Surg Oncol; 2022 Oct; 29(11):6867-6868. PubMed ID: 35616746
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Safety of Elective Esophagectomy Performed on Weekend for Patients with Esophageal Carcinoma.
    Yang TY; Chao YK
    Ann Surg Oncol; 2023 Jun; 30(6):3799. PubMed ID: 36905439
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Intramural Metastasis as Dismal Prognostic Factor in Esophageal Squamous Cell Carcinoma.
    Ushimaru Y; Makino T; Doki Y
    Ann Surg Oncol; 2023 Aug; 30(8):5203-5204. PubMed ID: 37285094
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: The Role of Skeletonizing en bloc Esophagectomy in Esophageal Squamous Cell Carcinoma.
    Kim DJ; Kim HE
    Ann Surg Oncol; 2022 Aug; 29(8):4918-4919. PubMed ID: 35419759
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: How Should We Approach Borderline Resectable Esophageal Squamous Cell Carcinoma?
    Suzuki T; Okamura A; Watanabe M; Chin K
    Ann Surg Oncol; 2020 May; 27(5):1518-1519. PubMed ID: 32108921
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Prognostic Role of a Coagulation Index for Patients with Esophageal Squamous Cell Cancer.
    Wang Q; Cao B; Mi K
    Ann Surg Oncol; 2021 Dec; 28(13):8462-8463. PubMed ID: 34106387
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic Value of a Modified Albumin-Bilirubin Score Designed for Patients with Esophageal Squamous Cell Carcinoma After Radical Resection.
    Shinozuka T; Kanda M; Shimizu D; Tanaka C; Inokawa Y; Hattori N; Hayashi M; Koike M; Kodera Y
    Ann Surg Oncol; 2022 Aug; 29(8):4889-4896. PubMed ID: 35381933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASO Author Reflections: Prognostic Significance of Kallikrein-Related Peptidase 13 Induction After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
    Shimomura A; Yamada K; Kawamura YI
    Ann Surg Oncol; 2024 Jan; 31(1):243-244. PubMed ID: 37851200
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Is Esophagectomy Necessary after Noncurative Endoscopic Resection for Early Esophageal Squamous Cell Carcinoma?
    Liu Z; Zhao J; Li Z
    Ann Surg Oncol; 2021 Nov; 28(12):7160-7161. PubMed ID: 34263374
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Additional Esophagectomy After Noncurative Endoscopic Resection Versus Upfront Esophagectomy in Patients with T1N0 Esophageal Squamous Cell Carcinoma.
    Maruyama S; Okamura A; Watanabe M
    Ann Surg Oncol; 2021 Sep; 28(9):4867-4868. PubMed ID: 33492541
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Serine Protease 27 is a Novel Prognostic Indicator for Esophageal Squamous Cell Carcinoma with Preoperative Treatment.
    Kataoka A; Yamada K; Kawamura YI
    Ann Surg Oncol; 2021 Sep; 28(9):5382-5383. PubMed ID: 33454876
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Response to Neoadjuvant Chemotherapy Strengthens the Prognostic Impact of Pathological Stage for Esophageal Squamous Cell Carcinoma.
    Matsuda S; Kawakubo H; Okamura A; Takahashi K; Toihata T; Takemura R; Mayanagi S; Takeuchi H; Watanabe M; Kitagawa Y
    Ann Surg Oncol; 2021 Dec; 28(13):8448-8449. PubMed ID: 34143335
    [No Abstract]   [Full Text] [Related]  

  • 17. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
    Fu X; Li T; Dai Y; Li J
    BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASO Author Reflections: Nodal Skip Metastasis Is Associated with Survival Benefit in Thoracic Esophageal Squamous Cell Carcinoma.
    Yang YS; Shang QX; Yuan Y; Chen LQ
    Ann Surg Oncol; 2021 Oct; 28(11):6353-6354. PubMed ID: 33543386
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: Esophagectomy or Chemoradiotherapy, That is the Question: Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma.
    Kanie Y; Okamura A; Asari T; Ishiyama A; Yoshio T; Tsuchida T; Chin K; Watanabe M
    Ann Surg Oncol; 2021 Dec; 28(13):8436-8437. PubMed ID: 34115253
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Esophageal Squamous Cell Carcinoma-Still a Conundrum.
    Squires MH; Salo JC
    Ann Surg Oncol; 2022 Feb; 29(2):1334-1335. PubMed ID: 34674090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.